News & Events about Lantern Pharma Inc.
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial PR Newswire BELTSVILLE, Md., May 3, 2023 BELTSVILLE, Md., May 3, 2023 /PRNewswire/ -- Reprocell USA, a CRO...
CNW Group - News Releases
1month ago
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Canada NewsWire BELTSVILLE, Md., May 3, 2023 BELTSVILLE, Md., May 3, 2023 /CNW/ -- Reprocell USA, a CRO...
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it has formed a...
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('AI') and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it has...
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('AI') and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced expansions and...